Sort
64,565 grants matching “drug discovery”
Advancing drug repositioning and development for Alzheimer's Disease using functional genomics and computational phenomics
$755,981Eric R Gamazon · Vanderbilt University Medical Center · R56 · FY2021 · AG
Plasmodium Protein Kinase Focused Antimalarials Discovery
$755,961Debopam Chakrabarti · University Of Central Florida · R01 · FY2025 · AI
Next-generation C-H functionalization methods for organic synthesis and their applications to biological inquiry
$755,936Jonathan A. Ellman · Yale University · R35 · FY2024 · GM
Next-generation C-H functionalization methods for organic synthesis and their applications to biological inquiry
$755,936Jonathan A. Ellman · Yale University · R35 · FY2025 · GM
Next-generation C-H functionalization methods for organic synthesis and their applications to biological inquiry
$755,936Jonathan A. Ellman · Yale University · R35 · FY2023 · GM
Next-generation C-H functionalization methods for organic synthesis and their applications to biological inquiry
$755,936Jonathan A. Ellman · Yale University · R35 · FY2022 · GM
Lead Optimization of DHODH Inhibitors for Malaria
$755,889Margaret A. Phillips · Ut Southwestern Medical Center · R01 · FY2023 · AI
Novel Antimalarials from Fungi
$755,877Debopam Chakrabarti · University Of Central Florida · R01 · FY2023 · AI
Genetic risk and long-term outcomes associated with Drug-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in survivors
$755,862Elizabeth Phillips · Vanderbilt University Medical Center · R01 · FY2020 · HG
Mechanisms of varied sensitivity of P. falciparum field isolates to the antimalarial drug pipeline
$755,690Philip Jon Rosenthal · University Of California, San Francisco · R01 · FY2018 · AI
Translation of GluN2B-selective PET radiopharmaceuticals in Alzheimers patients
$755,607Steven H Liang · Emory University · R01 · FY2025 · AG
Genetic Control of Addiction by Host and Microbiome
$755,605Jason A Bubier · Jackson Laboratory · U01 · FY2022 · DA
(Epi)genetic Risk Architectures in Opioid Dependent Brain
$755,523Peter Christopher Scacheri · Case Western Reserve University · R01 · FY2020 · DA
Fully modified bispecific aptamer for effective combination therapy of neovascular ocular diseases
$755,521Qiang Gong · Aptitude Medical Systems, Inc. · R44 · FY2023 · EY
Targeted Inhibition of Interleukin-1 beta to Prevent Preterm Birth
$755,520Kristina M Adams Waldorf · University Of Washington · R01 · FY2024 · HD
Drug Repurposing Screening for Rare and Neglected Diseases
$755,501Wei Zheng · National Center For Advancing Translational Sciences · ZIA · FY2025 · TR
Nonlipogenic ABCA1 inducers for ADRD
$755,497Gregory R J Thatcher · University Of Arizona · U01 · FY2023 · AG
Blocking a novel cytokine signaling pathway for the treatment of rheumatoid arthr
$755,418Kirill Ostanin · Navigen, Inc. · R44 · FY2015 · AR
Discovery of Addiction-Related Genes with Advanced Mouse Resources
$755,409Elissa J Chesler · Jackson Laboratory · R01 · FY2018 · DA
Lead Optimization of Novel Inhibitors of the Thioesterase Domain of FASN
$755,282Nicholas David Cosford · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2016 · CA
Lead Optimization of Novel Inhibitors of the Thioesterase Domain of FASN
$755,282Nicholas David Cosford · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2014 · CA
Lead Optimization of Novel Inhibitors of the Thioesterase Domain of FASN
$755,282Nicholas David Cosford · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2015 · CA
Development of 2C inhibitors as broad-spectrum enterovirus antivirals
$755,280Jun Wang · Rutgers Biomedical And Health Sciences · R01 · FY2024 · AI
A microphysiological system of tendon inflammation and fibrosis for drug screening and efficacy testing
$755,251Hani A Awad · University Of Rochester · UG3 · FY2021 · TR
New antifungals targeting the synthesis of fungal sphingolipids
$755,208Maurizio Del Poeta · State University New York Stony Brook · R01 · FY2024 · AI